Combined Antiviral and Antimediator Treatment of Rhinovirus Colds

Journal of Infectious Diseases

Volumn 166, Issue 4, 1992, Pages 776-782

  Gwaltney, Jack M ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; IPRATROPIUM BROMIDE; NAPROXEN;

ANTIBODY RESPONSE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EPISTAXIS; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN RHINOVIRUS; INTRANASAL DRUG ADMINISTRATION; NOSE IRRITATION; NOSE OBSTRUCTION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SORE THROAT; UPPER RESPIRATORY TRACT INFECTION; VIRUS INFECTIVITY; VIRUS TITRATION;

ADULT; COMMON COLD; DRUG THERAPY, COMBINATION; FEMALE; HUMAN; INTERFERON ALFA-2B; IPRATROPIUM; MALE; NAPROXEN; RHINOVIRUS;

EID: 0026757692     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/166.4.776     Document Type: Article

References (36)

1. Rossmann MG, Arnold E, Erickson JW, et al. The structure of a human common cold virus (rhinovirus 14) and its functional relations to other picornaviruses. Nature 1985;317:145-53.
2. Hayden F, Gwaltney J Jr. Colonno R. Modification of experimental rhinovirus colds by receptor blockade. Antiviral Res 1988;9:233-47.
3. Tomassini JE, Graham D, DeWitt CM, Lineberger DW, Rodkey JA, Colonno RJ. cDNA cloning reveals that the major group rhinovirus receptor on HeLa cells is intercellular adhesion molecule 1. Proc Natl Acad Sci USA 1989;86:4907-11.
4. Sperber SJ, Hayden FG. Chemotherapy of rhinovirus colds. Antimicrob Agents Chemother 1988;32:409-19.
5. 2treatment of experimental rhinovirus colds. J Infect Dis 1984;150:174-80.
6. Al-Nakib W, Higgins PG, Barrow Gl, et al. Suppression of colds in human volunteers challenged with rhinovirus by a new synthetic drug (R61837). Antimicrob Agents Chemother 1989;33:522-5.
7. serinein experimental rhinovirus colds. Arch Otolaryngol Head Neck Surg (in press).
8. Hayden FG, Andries K, Janssen PAJ. Safety and efficacy of intranasal pirodavir (R77975) in experimental rhinovirus infection. Antimicrob Agents Chemother 1992;36:727-32.
9. Naclerio RM, Proud D, Lichtenstein LM, et al. Kinins are generated during experimental rhinovirus cold. J Infect Dis 1988;157:133-42.
10. Proud D, Naclerio RM, Gwaltney JM Jr, Hendley JO. Kinins are generated in nasal secretions during natural rhinovirus colds. J Infect Dis 1990;161:120-3.
11. Gaffey MJ, Hayden FG, Boyd JC, Gwaltney JM Jr. Ipratropium bromide treatment of experimental rhinovirus infection. Antimicrob Agents Chemother 1988;32:1644-7.
12. Sperber SJ, Sorrentino JV, Riker DK, Hayden FG. Evaluation of an alpha agonist alone and in combination with a nonsteroidal antiinflammatory agent in the treatment of experimental rhinovirus colds. Bull NY Acad Med 1989;65:145-60.
13. Farr BM, Gwaltney JM Jr, Hendley JO, et al. A randomized controlled trial of glucocorticoid prophylaxis against experimental rhinovirus infection. J Infect Dis 1990; 162:1173-7.
14. Sperber SJ, Hendley JO, Hayden FG, Riker DK, Sorrentino JV, Gwaltney JM Jr. Effects of naproxen on experimental rhinovirus colds. Ann Intern Med 1992;117:37-41.
15. Gwaltney JM Jr, Colonno RJ, Hamparian VV, Turner RB. Rhinovirus. In: Schmidt NJ, Emmons RW, eds. Diagnostic procedures for viral, rickettsial and chlamydial infections. 6th ed. Washington, DC: American Public Health Association, 1989:604.
16. 2. Antiviral Res 1983;3:67-71.
17. Gwaltney JM Jr, Moskalski PB, Hendley JO. Interruption of experimental rhinovirus transmission. J Infect Dis 1980; 142:811-5.
18. Jackson GG, Dowling HF, Spiesman IG, Boand AV Transmission of the common cold to volunteers under controlled conditions. I. The common cold as a clinical entity. Arch Intern Med 1958:101:267-78.
19. Netter J, Wasserman W. Applied linear statistical models. Homewood, IL: Richard D. Irwin, 1974.
20. Rosner B. Fundamentals of biostatistics. 3rd ed. Boston: PWS Publishing, 1990.
21. Parekh HH, Cragun KT, Hayden FG, Hendley JO, Gwaltney JM Jr. Nasal mucus weights in experimental rhinovirus infection. Am J Rhinol 1992;6:107-10.
22. Gwaltney JM Jr, Hayden FG. Psychological stress and the common cold [letter], N Engl J Med 1992;326:644-5.
23. Phillpotts RJ, DeLong DC, Wallace J, Jones RW, Reed SE, Tyrrell DAJ. The activity of enviroxime against rhinovirus infection in man. Lancet 1981;1:1342-4.
24. Phillpotts RJ, Wallace J, Tyrrell DAJ, Tagart VB. Therapeutic activity of enviroxime against rhinovirus infection in volunteers. Antimicrob Agents Chemother 1983;23:671-5.
25. Al-Nakib W Higgins PG, Barrow I, Batstone G, Tyrrell DAJ. Prophylaxis and treatment of rhinovirus colds with zinc gluconate lozenges. J Antimicrob Chemother 1987;20:893-901.
26. Farr BM, Conner EM, Betts RF, Oleske J, Minnefor A, Gwaltney JM Jr. Two randomized controlled trials of zinc gluconate lozenge therapy of experimentally induced rhinovirus colds. Antimicrob Agents Chemother 1987;31:1183-7.
27. Gaffey MJ Gwaltney JM Jr. Sastre A, Dressier WE Sorrentino JV, Hayden FG. Intranasal and oral antihistamine treatment of experimental rhinovirus colds. Am Rev Respir Dis 1987;136:556-60.
28. Merigan TC, Reed SE, Hall TS, Tyrrell DAJ. Inhibition of respiratory virus infection by locally applied interferon. Lancet 1973;1:563-7.
29. Scott GM, Phillpotts RJ Wallace J Gauci CL, Greiner J, Tyrrell DAJ. Prevention of rhinovirus colds by human interferon alpha-2 from Escherichia coli. Lancet 1982;2:186-8.
30. Hayden FG, Gwaltney JM Jr. Intranasal interferon al for prevention of rhinovirus infection and illness. J Infect Dis 1983;148:543-50.
31. Samo TC, Greenberg SB, Palmer JM, Couch RB, Harmon MW, Johnson PE Intranasally applied recombinant leukocyte A interferon in normal volunteers. II. Determination of minimal effective and tolerable dose. J Infect Dis 1984;150:181-8.
32. Treanor JJ, Betts RF, Erb SM, Roth FK, Dolin R. Intranasally administered interferon as prophylaxis against experimentally induced influenza A virus infection in humans. J Infect Dis 1987;156:379-83.
33. 2-inter-feron. N Engl J Med 1986;314:71-5.
34. 2-interferon against rhinovirus infections in the family setting. N Engl J Med 1986;314:65-70.
35. Doyle WJ, Boehm S, Skoner DP. Physiologic responses to intranasal dose-response challenges with histamine, methacholine, bradykinin, and prostaglandin in adult volunteers with and without nasal allergy. J Allergy Clin Immunol 1990;81:924-35.
36. Gwaltney JM Jr, Moskalski PB, Hendley JO. Hand-to-hand transmission of rhinovirus colds. Ann Intern Med 1978;88:463-7.